search
Back to results

Effect of Circadian Light on Hospitalized Persons With Dementia and Older Adults With Cognitive Impairments.

Primary Purpose

Dementia, Cognitive Impairment

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Naturalistic LED light
Standard/traditional lighting
Sponsored by
Zealand University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Dementia

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with a recognized dementia diagnosis by the time of admission
  • Patients who, during admission, are found to have cognitive impairments
  • Patients who, during admission, are found to have delirium

Exclusion Criteria:

  • Patients with psychiatric conditions which in and of themselves might account for the patients' cognitive impairment will be excluded
  • Inability to speak (aphasia)
  • Patients with a linguistic or cultural background other than Danish
  • Patients with ongoing abuse of alcohol, narcotics or sedative pharmaceutics
  • Patients with impaired level of consciousness due to other causes than delirium.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Sham Comparator

    Arm Label

    Intervention group

    Control group

    Arm Description

    Exposure to 24-hour LED naturalistic lighting

    Exposure to standard/traditional lighting setting with fluorescent tubes

    Outcomes

    Primary Outcome Measures

    Cortisol
    Cortisol levels measured in saliva samples

    Secondary Outcome Measures

    Delirium
    Delirium measured in CAM score
    Length of admission
    Length of admission collected from patient charts
    Pharmaceutics
    Use of pharmaceutics during hospitalization. Collected from patient charts.
    Mortality
    Mortality rates collected from patient charts
    Adverse advent
    Adverse advent, e.g. patient related fall incidents, collected from patient charts
    Constant observation
    Need of constant observation from health professionals, collected from patient charts

    Full Information

    First Posted
    September 6, 2022
    Last Updated
    September 6, 2022
    Sponsor
    Zealand University Hospital
    Collaborators
    Technical University of Denmark, University of Copenhagen
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05535790
    Brief Title
    Effect of Circadian Light on Hospitalized Persons With Dementia and Older Adults With Cognitive Impairments.
    Official Title
    PAX: A Randomized Single-blind Controlled Trial of the Effect of Circadian Light on Hospitalized Persons With Dementia and Older Adults With Cognitive Impairments
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 1, 2022 (Anticipated)
    Primary Completion Date
    January 1, 2024 (Anticipated)
    Study Completion Date
    May 1, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Zealand University Hospital
    Collaborators
    Technical University of Denmark, University of Copenhagen

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Light stimulates the human visual system and the biological functions in the retina, also referred to as non-visual responses, e.g. hormone production. Exposure to the correct light composition can produce acute alertness and increase good sleep quality (1). In this study, subjects will be exposed to 24-hour LED naturalistic lighting (intervention) or traditional lighting (control) during all days of hospitalization. Subjects will be blinded to the intervention as they will not be told if they are admitted to an intervention patient room or a control patient room. The primary outcome measure is cortisol levels measured in saliva samples. Secondary outcome measures are delirium rates, length of admission, use of constant observation, mortality and adverse advent. It is estimated that 80 subjects will be included in the study.
    Detailed Description
    During hospitalization, patient rooms are often associated with poor lighting conditions, and patients are often not exposed to outdoor activities. Many patients have difficulties sleeping during hospital admission, which affects health outcomes and potentially leads to prolonged admission and rehabilitation and a higher risk of developing delirium. However, the circadian rhythm can be modified with LED light, as this technology can reach sufficient levels to affect the human melanopic equivalent daylight illuminance (Melanopic EDI). A high melanopic EDI during the day is supportive for alertness and a good night's sleep. A good night's sleep is essential to prevent the development of delirium. LED lighting, which can give melanopic EDI, is called naturalistic light (1,2). In this study, subjects will be exposed to 24-hour LED naturalistic lighting (intervention) or traditional lighting of fluorescent tubes (control) during all days of hospitalization. Subjects will be blinded to the intervention as they will not be told if they are admitted to an intervention patient room or a control patient room. The study includes subjects who are diagnosed with dementia (mild-moderate) or older adults (+65 years) who have cognitive impairments. Subjects will be screened before inclusion using a mini-mental state examination (MMSE) (3) and clinical examination by trained specialists. To test the effect of exposure to circadian light, the study is designed as a single-centre exploratory parallel-arm randomized controlled trial. The trial will be thoroughly reported according to the CONSORT (4) statement extended guidelines The primary outcome measure is cortisol levels measured in saliva samples. The samples are collected two times each day during hospitalization. One sample is collected at <30 minutes after the subject has woken in the morning (during the morning cortisol peak) and one sample in the evening when the highest level is expected. Secondary outcome measures are delirium rates, length of admission, need for escape prevention, mortality, use of antipsychotics and adverse advent e.g. patient related fall incidents. Delirium rates are collected by performing a confusion assessment method (CAM) (5) score two times a day. Additional measurements are collected in patient charts. To reach sufficient power, we estimate that 80 subjects will be included in the study. 40 subjects are admitted to the intervention room (with naturalistic lighting), and 40 are admitted to the control room (traditional/standard lighting conditions).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Dementia, Cognitive Impairment

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    80 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Intervention group
    Arm Type
    Experimental
    Arm Description
    Exposure to 24-hour LED naturalistic lighting
    Arm Title
    Control group
    Arm Type
    Sham Comparator
    Arm Description
    Exposure to standard/traditional lighting setting with fluorescent tubes
    Intervention Type
    Other
    Intervention Name(s)
    Naturalistic LED light
    Intervention Description
    Naturalistic LED light (bright light therapy) which affects Melanopic Equivalent Daylight Illuminance.
    Intervention Type
    Other
    Intervention Name(s)
    Standard/traditional lighting
    Intervention Description
    Standard/tradtional lighting environment with fluorescent tubes
    Primary Outcome Measure Information:
    Title
    Cortisol
    Description
    Cortisol levels measured in saliva samples
    Time Frame
    During intervention period
    Secondary Outcome Measure Information:
    Title
    Delirium
    Description
    Delirium measured in CAM score
    Time Frame
    During intervention period
    Title
    Length of admission
    Description
    Length of admission collected from patient charts
    Time Frame
    During intervention period
    Title
    Pharmaceutics
    Description
    Use of pharmaceutics during hospitalization. Collected from patient charts.
    Time Frame
    During intervention period
    Title
    Mortality
    Description
    Mortality rates collected from patient charts
    Time Frame
    During intervention period
    Title
    Adverse advent
    Description
    Adverse advent, e.g. patient related fall incidents, collected from patient charts
    Time Frame
    During intervention period
    Title
    Constant observation
    Description
    Need of constant observation from health professionals, collected from patient charts
    Time Frame
    During intervention period

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients with a recognized dementia diagnosis by the time of admission Patients who, during admission, are found to have cognitive impairments Patients who, during admission, are found to have delirium Exclusion Criteria: Patients with psychiatric conditions which in and of themselves might account for the patients' cognitive impairment will be excluded Inability to speak (aphasia) Patients with a linguistic or cultural background other than Danish Patients with ongoing abuse of alcohol, narcotics or sedative pharmaceutics Patients with impaired level of consciousness due to other causes than delirium.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Martin Ballegaard, MD, PhD
    Phone
    (+45) 47 32 29 09
    Email
    mbag@regionsjaelland.dk
    First Name & Middle Initial & Last Name or Official Title & Degree
    Lotte Olsen, MSc
    Phone
    (+45) 42 60 10 21
    Email
    losol@regionsjaelland.dk

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    30416392
    Citation
    Figueiro MG, Nagare R, Price L. Non-visual effects of light: how to use light to promote circadian entrainment and elicit alertness. Light Res Technol. 2018;50(1):38-62. doi: 10.1177/1477153517721598. Epub 2017 Jul 25.
    Results Reference
    background
    PubMed Identifier
    28534696
    Citation
    Figueiro MG. Light, sleep and circadian rhythms in older adults with Alzheimer's disease and related dementias. Neurodegener Dis Manag. 2017 Apr;7(2):119-145. doi: 10.2217/nmt-2016-0060. Epub 2017 May 23.
    Results Reference
    background
    PubMed Identifier
    26760674
    Citation
    Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, Thom VM, Nash KJ, Elhamoui H, Milligan R, Patel AS, Tsivos DV, Wing T, Phillips E, Kellman SM, Shackleton HL, Singleton GF, Neale BE, Watton ME, Cullum S. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016 Jan 13;2016(1):CD011145. doi: 10.1002/14651858.CD011145.pub2.
    Results Reference
    background
    PubMed Identifier
    20334633
    Citation
    Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010 Mar 24;8:18. doi: 10.1186/1741-7015-8-18.
    Results Reference
    background
    PubMed Identifier
    18384586
    Citation
    Wei LA, Fearing MA, Sternberg EJ, Inouye SK. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc. 2008 May;56(5):823-30. doi: 10.1111/j.1532-5415.2008.01674.x. Epub 2008 Apr 1.
    Results Reference
    background

    Learn more about this trial

    Effect of Circadian Light on Hospitalized Persons With Dementia and Older Adults With Cognitive Impairments.

    We'll reach out to this number within 24 hrs